CAR T cells derived from a novel, high-affinity anti-CLL-1 monoclonal antibody exhibit a significant anti-AML effect

Abstract CAR T cells targeting CLL-1 have shown antileukemia efficacy in patients with acute myeloid leukemia (AML). However, CLL-1low/− AML cells are present in some patients, suggesting that the development of CAR T cells with high sensitivity is necessary to eradicate all AML clones in these pati...

全面介紹

書目詳細資料

Principais autores:	Shuhei Kida, Makiko Suga, Yuta Yamaguchi, Shunya Ikeda, Yosuke Kogue, Ryuhei Kawamoto, Kumi Shibata, Kazuhito Tsutsumi, Hiraku Murakami, Emiko Mizuta, Yo Mizutani, Naoki Hosen
格式:	Artigo
語言:	Inglês
出版:	Springer 2026-03-01
叢編:	Cancer Immunology, Immunotherapy
主題:	CAR T cells AML CLL-1 Revumenib Menin inhibitor
在線閱讀:	https://doi.org/10.1007/s00262-026-04342-x
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!